Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the antiemetics and antinauseants market grown over the years?

Over the past few years, the market size for antiemetics and antinauseants has consistently increased. The market is predicted to expand from $8.11 billion in 2024 to $8.45 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.3%. The growth observed in the historic period is due to factors such as traditional branding and market competition, previous treatment preferences, the state of the economy, significant historical health events, and advancements in medical research and technology.

What Is the forecasted market size and growth rate for the antiemetics and antinauseants market?

Predictions suggest that the roofing market will maintain consistent growth in the forthcoming years, with a valuation estimated to reach $370.41 billion in 2029, representing a compound annual growth rate (CAGR) of 3.9%. Multiple factors are contributing to this expected growth during the forecast timeframe, including sustainable and environment-friendly practices, resistance to severe weather conditions, innovative roofing materials, and energy-efficient standards. Moreover, the impact of government regulations and building codes should not be underestimated. Noticeable trends for the estimated period comprise aesthetic and personalized trends in roof design, the adoption of green roofing practices, a move towards lightweight and modular roofing solutions, a focus on weather-resistant coatings, and sealants as well as technological advancements in roofing installation and maintenance processes.

Get your antiemetics and antinauseants market report here!

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What are the major factors driving growth in the antiemetics and antinauseants market?

The antiemetics and antinauseants market’s growth is propelled by the rising incidence of cancer. Cancer can often be treated through chemotherapy, which unfortunately comes with side effects like chemotherapy-induced nausea and vomiting (CINV). Fortunately, antiemetics have been found to mitigate CINV in approximately 60%-70% of patients. According to a forecast from The American Cancer Society, a US-based non-profit organization, in April 2024, around 609,000 cancer-related deaths were reported, with a projected 1.9 million new cancer cases diagnosed in 2022. The projected number of cancer fatalities is estimated at 620,000 which signifies a slight upsurge in mortality rates in 2024. The escalating cancer incidence paves the way for a surge in the demand for antiemetics and antinauseants, ultimately spurring market revenue.

What key areas define the segmentation of the global antiemetics and antinauseants Market?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What are the top market players propelling the growth of the antiemetics and antinauseants industry?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

What are the key trends shaping the future of the antiemetics and antinauseants market?

Leading businesses active in the antiemetic and antinauseant marketplace are focusing on developing innovative products such as ready-to-use injectable solutions, with the aim to streamline treatment procedures and improve patient adherence. These pre-produced formulations are engineered to provide instant effectiveness, thereby reducing the time and the intricacy involved with conventional injectable drugs. As an example, in July 2024, Amneal Pharmaceuticals, a specialty pharmaceutical firm based in the US, introduced FOCINVEZ, the first ready-to-use injectable edition of fosaprepitant, intended for preventing acute and delayed nausea and vomiting related to highly emetogenic cancer chemotherapy. This product is obtainable as a 150 mg/50 mL vial, is Polysorbate 80 free, and removes the need for reconstitution or dilution, enabling immediate administration. FOCINVEZ has been authorized for use in adults and pediatric patients from six months of age and has received a distinctive J-Code (J1434) for reimbursement.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

What regions are dominating the antiemetics and antinauseants market growth?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cough And Cold Preparations Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Smart Healthcare Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-healthcare-products-global-market-report

Smart Pills Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: